KRISTIE KOKENY: Open Payments
NPI 1437669405 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 32 payments from 12 companies in 2025. Trend: 2023 $900 · 2024 $706 · 2025 $1,043
Food & beverage: $975Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $335 |
| Dendreon Pharmaceuticals LLC | 3 | $224 |
| Sumitomo Pharma America, Inc. | 9 | $174 |
| 180 Medical, Inc. | 2 | $57 |
| ACCORD HEALTHCARE, INC. | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| ABBVIE INC. | 2 | $39 |
| UROGEN PHARMA, INC. | 1 | $30 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $26 |
| PFIZER INC. | 1 | $24 |
Products named: RYBREVANT, PROVENGE, ORGOVYX, ERLEADA, GEMTESA, Camcevi, KEYTRUDA, LUPRON DEPOT.
Industry payments across NY — which companies pay providers there.
